VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1811421
Sex: F
Age:
State: WV

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Extreme headache; Nausea; Fever; Chills; Sweating; Pain in joints; Hurt to touch skin anywhere; Total loss of appetite; Could not walk without help; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 17:00 (at the age of 70-year-old), as a single dose for COVID-19 immunisation. Medical history included known allergy to sulpha. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E?8732) via an unspecified route of administration in the left arm on 26Mar2021 at 18:00 (at the age of 70-year-old), as a single dose for COVID-19 immunisation. On 16Apr2021 at 06:00, the patient experienced extreme headache, nausea, fever, chills, sweating, pain in joins, hurt to touch skin anywhere, total loss of appetite and could not walk without help. The patient also reported that, pain was worse on skin than any pain she has ever had in her life. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme headache, nausea, fever, chills, sweating, pain in joins, hurt to touch skin anywhere, total loss of appetite and could not walk without help was resolved on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1811422
Sex: F
Age:
State: GA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Flushing of the face; Sudden racing heart; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8731) via an unspecified route of administration in the left arm on 13Apr2021 at 17:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19.Concomitant medications included xantofyl, zeaxanthin (AREDS 2), vitamin d nos (MANUFACTURER UNKNOWN) and probiotics (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously took acetylsalicylic acid(ASPIRIN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 18:00 the patient experienced flushing of the face and sudden racing heart. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event flushing of the face and sudden racing heart was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LUTEIN ZEAXANTHIN; VITAMIN D NOS

Current Illness:

ID: 1811423
Sex: F
Age:
State: MA

Vax Date: 04/10/2021
Onset Date: 04/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: I am experiencing an irregular menstrual cycle; Severe cramping in my lower back and lower abdomen; Severe cramping in "my" lower back and lower abdomen.; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 10Apr2021 at 09:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic to kiwi (fruit allergy). Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medications included levonorgestrel (MIRENA) and salbutamol (ALBUTEROL); all used for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 08:00, the patient experienced an irregular menstrual cycle. She normally had only spot if anything at all. Not this time and it was at least 2 weeks early. She also reported for severe cramping in patient lower back and lower abdomen. Normally she had nothing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events irregular menstrual cycle and severe cramping in her lower back and lower abdomen was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: MIRENA; ALBUTEROL [SALBUTAMOL]

Current Illness:

ID: 1811424
Sex: F
Age:
State: CA

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Date: 20210411; Test Name: Body temperature; Result Unstructured Data: Test Result:Low grade fever of 99

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Intense sharp pains that jumped all over body that would last 1-3 min per spot and then jump to another body part; Right forearm and buttock cheeks were most painful; Right forearm and buttock cheeks were most painful; Very uncomfortable to sleep; Chills; Low grade fever of 99; Large heat rash around injection site with some arm swelling appeared; Large heat rash around injection site with some arm swelling appeared; Lymph nodes under left arm were very tender and swollen; Lymph nodes under left arm were very tender and swollen; Left tonsil swelling making for difficult swallowing; Left tonsil swelling making for difficult swallowing; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8729) via an unspecified route of administration in the left arm on 10Apr2021 at 10:38 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included supraventricular tachycardia. The patient had known allergies to unspecified medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 11Apr2021, the patient woke up at 01:00 with intense sharp pains that jumped all over body that would last 1-3 minutes per spot and then jumped to another body part. It was reported that right forearm and buttock cheeks were most painful and very uncomfortable to sleep. These all events lasted until morning. On 11Apr2021, chills set in around 05:00. On the same day (Sunday), the patient experienced low grade fever of 99 (unspecified unit) all day. On the same day by afternoon, lymph nodes under left arm were very tender and swollen, lasted for 7 days along with left tonsil swelling and making for difficult swallowing, lasted for 10 days. At evening, large heat rash around injection site with some arm swelling appeared which was slowly disappeared in 8 days. On 11Apr2021, the patient underwent body temperature test and the result was low grade fever of 99 (unspecified unit). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense sharp pains that jumped all over body that would last 1-3 min per spot and then jump to another body part, right forearm and buttock cheeks were most painful and very uncomfortable to sleep was resolved on 11Apr2021. The clinical outcome of the events lymph nodes under left arm were very tender and swollen was resolved on 18Apr2021. The clinical outcome of the events large heat rash around injection site with some arm swelling appeared was resolved on 19Apr2021. The clinical outcome of the events left tonsil swelling making for difficult swallowing was resolved on 21Apr2021 and outcome of the events chills and low grade fever of 99 was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811425
Sex: F
Age:
State: VA

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Headache; Nausea; Heaviness in "my" chest; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 19Apr2021 at 13:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history and Concomitant medication was not reported. The patient previously received AMPICILLIN, on an unspecified date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UA7533) via an unspecified route of administration in the left arm on 19Apr2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 07:00, the patient experienced headache, nausea, and heaviness in her chest. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, and heaviness in chest were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811426
Sex: F
Age:
State: NY

Vax Date: 04/25/2021
Onset Date: 04/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Cough; Chills; Fatigue; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 25Apr2021 at 12:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included zolpidem tartrate (AMBIEN), alprazolam (XANAX), diphenhydramine / paracetamol / phenylpropanolamine hydrochloride (BENADRYL) and paracetamol (TYLENOL); for unknown indication from unknown dates and unknown if ongoing. The patient previously took morphine (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 04Apr2021 at 12:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 13:30, the patient experienced cough, chills, fatigue and sore throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events cough, chills, fatigue and sore throat was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMBIEN; XANAX; BENADRYL; TYLENOL

Current Illness:

ID: 1811427
Sex: F
Age:
State: NY

Vax Date: 04/23/2021
Onset Date: 04/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: very itchy and hot shoulder around injection site 48 hrs after injection; very itchy and hot shoulder around injection site 48 hrs after injection; Rash (small red bumps, itchy) on left hand 36 hrs after injection; Rash (small red bumps, itchy) on left hand 36 hrs after injection; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 23Apr2021 at 17:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 16:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 05:45, 36 hours after injection, the patient experienced rash (small red bumps, itchy) on left hand. On 25Apr2021 at 17:45, 48 hours after injection, the patient experienced very itchy and hot shoulder around injection site. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash (small red bumps, itchy) on left hand and very itchy and hot shoulder around injection site was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1811428
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Redness; Extreme itching; Rash; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on an unspecified date (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced redness, extreme itching and rash. The events resulted in a visit to the doctors or other healthcare professional office/clinic. Therapeutic measures were taken as a result of the events. The clinical outcome of the events redness, extreme itching and rash was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811429
Sex: M
Age:
State:

Vax Date:
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Arm hurts; Headache; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 21Apr2021, the patient experienced arm hurts, headache and fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm hurts, headache and fever was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811430
Sex: F
Age:
State: MN

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Facial tingling- was on the bottom half of face, mostly around mouth; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 30Mar2021 at 12:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within 2 weeks of COVID-19 vaccine. On 30Mar2021 at 12:45, the patient experienced facial tingling on the bottom half of face, mostly around mouth, which came and went for a few days and very sporadically after that. The patient had no swelling or any other concerns. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event facial tingling around mouth was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811431
Sex: F
Age:
State: MA

Vax Date: 04/17/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Cold sores; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to penicillin and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications . On 19Apr2021 at 23:00, the patient experienced cold sores. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event cold sores and included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event cold sores was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811432
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Lymph nodes inflation, under the right armpit.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on an unknown date in 2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Apr2021, the patient experienced lymph nodes inflation, under the right armpit. It was reported that it could be felt and seen from the outside. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lymph nodes inflation, under the right armpit was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811433
Sex: F
Age:
State: CT

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Day of the shot developed chills and lots of numbness in hand/arm.; Fatigue; Day of the shot developed chills; Lethargy; Severe headache. Headache has been off and on ongoing since shot, sometimes severe reoccurrences; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 19Apr2021 at 10:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Apr2021 at 10:45, on the day of the shot, the patient experienced chills and lots of numbness in hand/arm. Day after worsened chills, fatigue, lethargy, severe headache. Headache had been off and on ongoing since shot, sometimes severe reoccurrences. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the event chills and lots of numbness in hand/arm, fatigue, lethargy, severe headache was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1811434
Sex: F
Age:
State:

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: 40 hour Fever; Swollen lymph nodes in armpits; 24 hours body aches; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW 0172) via an unspecified route of administration in the left arm on 18Apr2021 at 12:15 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease, known allergies to soy and tuna. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT) and birth control pills (MANUFACTURER UNKNOWN), both for an unknown indication from an unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8734) via an unspecified route of administration in the left arm on 28Mar2021 at 12:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 00:00, the patient experienced 40 hours fever, swollen lymph nodes in armpits, 24 hours body aches and chills. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, axillary lymph nodes enlarged, body aches and chills were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ZOLOFT

Current Illness:

ID: 1811435
Sex: F
Age:
State: CO

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Painful, large, circular rashes around both armpits approx. 26 hours after injection; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 24Apr2021 at 10:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other concomitant medications within two weeks of vaccination. On 25Apr2021 at 12:30, the patient experienced painful, large, circular rashes around both armpits approximately 26 hours after injection. The events did not result in doctor or other health care professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event painful, large, circular rashes around both armpits was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811436
Sex: F
Age:
State: NC

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Extremely fatigued; Reduction in energy level; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 14Apr2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, type 2 diabetes and asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:ER8727) via an unspecified route of administration in the right arm on 23Mar2021 at 14:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 09:00, the patient had been extremely fatigued and had a noticeable reduction in energy level since the day after receiving second dose. She was unsure if it is related or merely coincidental but felt that she should report it just in case. No therapeutic measures were taken as a result of the events. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely fatigued and had a noticeable reduction in energy level was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811437
Sex: F
Age:
State: TX

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210415; Test Name: Body temperature; Result Unstructured Data: Test Result:101.2 (unspecified units)

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Fever; Cervical lymph nodes swelling; Body pain; A lot of tiredness; Muscle aches; This is a spontaneous report from a contactable nurse. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via intramuscular route of administration in the left arm on 14Apr2021 at 16:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 19Mar2021 at 16:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 17:15, next day after vaccination, the patient experienced a lot of tiredness and muscle aches. On 20Apr2021, 6 days after vaccination, the patient experienced 101.2 fever, cervical lymph nodes swelling and body pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (MOTRIN) and paracetamol (TYLENOL). On 15Apr2021, the patient underwent body temperature test and the result was 101.2 (unspecified unit). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events a lot of tiredness, muscle aches, 101.2 fever, cervical lymph nodes swelling and body pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; LEVOTHYROXINE

Current Illness:

ID: 1811438
Sex: F
Age:
State: OH

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210423; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Shortness of breath/ out of breath walking around the house; Chest tightness /Feel a constant pressure on chest.; Shortness of breath and chest tightness with fatigue.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 12:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included vedolizumab (ENTYVIO) for an unknown indication from an unknown start date and unknown if ongoing. On 17Apr2021 at 12:30, immediately after receiving the vaccine, the patient had shortness of breath and chest tightness with fatigue. To date on 23Apr2021, the symptoms had not subsided. As on 23Apr2021, the patient had tested negative for COVID-19. The patient's vitals were fine. However, the patient was out of breath walking around the house and felt a constant pressure on the chest. The patient was physically active and normally worked out approximately 5 days a week. Being short of breath, with chest tightness was not something the patient was accustomed to. The patient had been assessed by a medical professional and did not have any other symptoms or fluid in my lungs. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 23Apr2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The clinical outcome of the events shortness of breath, chest tightness with fatigue, out of breath walking around the house and felt a constant pressure on the chest was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ENTYVIO

Current Illness:

ID: 1811439
Sex: F
Age:
State: PA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Ears are ringing since the day after the injection; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 25Mar2021 (at the age of 55-years-old) as a single dose for COVID-19 immunization. Medical history included obese (obesity) and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19 immunization. On 26Mar2021 at 20:00, since the day after the injection the patient felt ears were ringing. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ears is ringing since the day after the injection was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811440
Sex: F
Age:
State: NE

Vax Date: 03/09/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Severe swelling around the eye area; Redness around the eye area; Itching around the eye area; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Mar2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced severe swelling, redness, and itching around the eye area. The events resulted in emergency room/department visits or urgent care. The events resulted in doctor or other healthcare professional office/clinic visits. Therapeutic measures were taken as a result of the events included treatment with unspecified steroid. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe swelling, redness, and itching around the eye area were resolved on an unknown date in Apr2021. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811441
Sex: F
Age:
State: NY

Vax Date: 04/17/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210423; Test Name: SARS-CoV-2 test; Test Result: Negative ; Comments: Blood test

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Severe body aches; Shortness of breath; Chest pains; Brain fog; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 at 13:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unspecified birth control medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took sulfur (MANUFACTURER UNKNOWN) and experienced drug allergy. On 22Apr2021 at 23:00, the patient experienced severe body aches, shortness of breath, chest pains, brain fog and fatigue. On 23Apr2021, the patient underwent SARS-CoV-2 test (blood test) and the result was negative. The event resulted in emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events severe body aches, shortness of breath, chest pains, brain fog and fatigue was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811442
Sex: F
Age:
State: DC

Vax Date: 04/25/2021
Onset Date: 04/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210425; Test Name: Body temperature; Result Unstructured Data: Test Result:101.5; Comments: Fever (101.5)

Allergies:

Symptom List: Unevaluable event

Symptoms: Sore arm; Fever (101.5); Chills; Aches; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 25Apr2021 at 08:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa and nickel. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 04Apr2021 at 08:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 22:30, the patient experienced sore arm, fever (101.5), chills and aches. On the same day, the patient underwent body temperature test and the result was 101.5 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, fever (101.5), chills and aches was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT

Current Illness:

ID: 1811443
Sex: F
Age:
State: ME

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Muscle spasm in my right eyebrow that has been ticking every 10 minutes for over 24 hours; Muscle spasm in my right eyebrow that has been ticking every 10 minutes for over 24 hours; Left arm in pain; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 00161) via an unspecified route of administration in the left arm on 24Apr2021 at 13:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, autoimmune pancreatitis, allergy and asthma; all from unknown date and unknown if ongoing at the time of this report. Concomitant medications included cetirizine hydrochloride (ZYRTEC), fluticasone propionate/salmeterol xinafoate (ADVAIR) and salbutamol (ALBUTEROL); all on an unknown date for unknown indication. The patient previously received amitriptyline (MANUFACTURER UNKNOWN) and morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 18:00, the patient experienced, left arm in pain (the patient was told about this) and muscle spasm in the right eyebrow that has been 'ticking' every 10 minutes for over 24 hours and this was concerning for the patient. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm in pain and muscle spasm in the right eyebrow that has been 'ticking' was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ADVAIR; ALBUTEROL [SALBUTAMOL]

Current Illness:

ID: 1811444
Sex: F
Age:
State: OK

Vax Date: 12/24/2020
Onset Date: 03/15/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210329; Test Name: COVID-19 virus test; Test Result: Negative; Comments: Nasal Swab

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Rash on trunk and legs not going away; Rash on trunk , arms, and legs not going away.; Papular; Rash on trunk , arms, and legs not going away. Papular, itches, and burns; This is a spontaneous report from a contactable nurse, the patient. A 34-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 24Dec2020 at 00:00 (at the age of 34-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known drug allergies (NKDA). Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. On 15Mar2021 at 00:00, the patient experienced rash on trunk, arms and legs and was not going away. The rash was papular, itched and burned. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as the result of the events and included treatment with Me from dose pack (as reported). Since the vaccination, the patient had been tested for COVID-19. On 29Mar2021, the patient underwent COVID-19 virus test (via nasal swab) and the result was negative. The clinical outcome of the events rash on trunk, arms and legs; papular, itches and burns was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811445
Sex: F
Age:
State: FL

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Could not stand for very long; Stomach hurt very bad; Diarrhea; Severe gas pains; Intercostal muscles started hurting very bad; Painful to breathe; Neuro pain from injection site down arm to fingers; Interdigital space between digits 1 and 2 went numb; Fatigue; Ache muscles; This is a spontaneous report from a contactable healthcare professional, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 23Apr2021 at 14:15 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic atopy, chronic sinusitis, degenerative joint disease, lyme disease and very severe reaction to rabies vaccine all from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included paracetamol (TYLENOL), levocetirizine dihydrochloride (XYZAL), multivitamin and glucosamine /chon/msm (GLUCOSAMIN) all for unspecified indication from an unknown date and unknown if ongoing. The patient previously took local anesthesia, aminobenzoic acid(PABA), opioids, fluoxetine hydrochloride(PROZAC) and misoprostol(MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 01Apr2021 at 14:15 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 14:15 immediately after injection the patient experienced neuro pain from injection site down arm to fingers. Interdigital space between digits 1 and 2 went numb. With 30 min of vaccination fatigue started, similar to flu, with ache muscles. On 24Apr2021, next morning fatigue was worse. Throughout day fatigue became extreme, extreme muscle aches, could not stand for very long, stomach hurt very bad, diarrhea started and severe gas pains. Intercostal muscles started hurting very bad and made it very painful to breathe. The patient did not have health insurance, therefore did not to doctor. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events neuro pain from injection site down arm to fingers, interdigital space between digits 1 and 2 went numb, fatigue, ache, could not stand for very long, stomach hurt very bad, diarrhea, severe gas pains, intercostal muscles started hurting very bad and painful to breathe were resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; XYZAL; GLUCOSAMIN [GLUCOSAMINE]

Current Illness:

ID: 1811446
Sex: M
Age:
State: MA

Vax Date: 04/13/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210418; Test Name: Heart rate; Result Unstructured Data: Test Result:increased

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Irregular increased heart beats and faster heart beats; Irregular heart beats; Increased chest discomfort; Coughing; Disruption of speeches; Affected sleep; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 13Apr2021 at 12:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified blood thinner, for an unknown indication from an unknown date and unknown if ongoing. On 18Apr2021, the patient began to experience irregular increased heart beats, and faster heart beats, increased chest discomfort starting about 5 days following the first dose of shot. It happened throughout the day. It happened during seating and sleeping. The irregular heartbeats and chest discomfort caused coughing and disruption of speeches. It began to become severe and affected sleeping. The events resulted in doctor or other healthcare professional office/clinic visit. On 18Apr2021, the patient underwent heart rate test and the result was increased. It was unknown if the patient received any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events irregular increased heart beats and faster heart beats, increased chest discomfort, coughing, disruption of speeches and affected sleep was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811447
Sex: F
Age:
State: MD

Vax Date: 04/01/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210418; Test Name: Nasal swab; Result Unstructured Data: Test Result:Pending

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fever; chills; headaches; sore throat; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 16:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included hydrochloride (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 06:30, the patient experienced lymph node armpit, fever, chills headaches and sore throat. On 18Apr2021, the patient underwent nasal swab and the result was pending. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with amoxicillin 875 (MANUFACTURER UNKNOWN). Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events lymph node armpit, fever, chills headaches and sore throat was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811448
Sex: F
Age:
State: GA

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Swollen and painful lymph nodes in the left armpit area; Swollen and painful lymph nodes in the left armpit area; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 22Apr2021 at 13:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included cetirizine hydrochloride (ZYRTEC ALLERGY) from 20Apr2021 at 23:30 taken for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 31Mar2021 at 12:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient previously received paracetamol; oxycodone hydrochloride; oxycodone terephthalate (PERCOCET) taken for an unknown indication and experienced drug allergy. On 23Apr2021 at 08:00, the patient had swollen and painful lymph nodes in the left armpit area. The swelling and pain occurred approximately 18 hours later. It had been 3 days with the swelling and painful lymph nodes (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen and painful lymph nodes in the left armpit area was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC ALLERGY

Current Illness:

ID: 1811449
Sex: F
Age:
State: NY

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: persistent chills and body aches for 3 days; Severe heat rash down the entire left side of neck.; Lymph node swelling under bicep and in arm pit; Redness around injection site; Itchiness on upper back.; persistent chills and body aches for 3 days; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Concomitant medications included sumatriptan (IMITREX), verapamil (MANUFACTURER UNKNOWN) and lactobacillus nos (CULTURELLE); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021, the patient experienced persistent chills and body aches for 3 days, redness around injection site with lymph node swelling under bicep and in arm pit along with a severe heat rash down the entire left side of neck and she also had itchiness on upper back. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events persistent chills and body aches for 3 days was resolved on 23Apr2021. The clinical outcome of the events redness around injection site with lymph node swelling under bicep and in arm pit along with a severe heat rash down the entire left side of neck and itchiness on upper back was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: IMITREX; VERAPAMIL; CULTURELLE

Current Illness:

ID: 1811450
Sex: F
Age:
State: TX

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Light pain in left arm; Fever; Chills; Muscle pain all over the body; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 10:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levonorgestrel (MIRENA) from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 03Apr2021 at 17:30 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. On 25Apr2021 at 04:00 the patient felt light pain in left arm during the day. Then in the middle of the night pain got sharper and had fever, chills, and muscle pain all over the body, which remained for whole next day and night. The following morning the patient had very sharp arm pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events light pain in left arm, fever, chills and muscle pain all over the body were ongoing at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: MIRENA

Current Illness:

ID: 1811451
Sex: F
Age:
State: MI

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: On April 24th, 5 days after the vaccine, "I" started "my" period. "I" am on BC that makes "me" not have "my" period. "I" am still taking "my" pill as normal, but "I" am experiencing a heavy flow and painful cramps.; On April 24th, 5 days after the vaccine, "I" started "my" period. "I" am on BC that makes "me" not have "my" period. "I" am still taking "my" pill as normal, but "I" am experiencing a heavy flow and painful cramps.; "I" was drinking so much and hardly peeing at all.; "I" was drinking so much and hardly peeing at all.; The night after getting the vaccine and carrying over through the next day, was excessively thirsty. "I" was drinking so much and hardly peeing at all.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm right on 19Apr2021 at 13:30(at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included birth control. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The concomitant medications included bupropion hydrochloride (WELLBUTRIN XL) for unspecified indication and norethisterone (NORETHINDRONE) for birth control, all from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 26Mar2021 at 14:00(at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021, the night after getting the vaccine and carrying over through the next day, the patient was excessively thirsty and was drinking so much and hardly peed at all. On 24Apr2021 at 07:00, 5 days after the vaccine the patient's period started. She was on her birth control (BC) that made her not had her period. She was taking her pill as normal at the time of report, but experienced a heavy flow and painful cramps. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events excessively thirsty, drinking so much, hardly peed, a heavy flow and painful cramps were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN XL; NORETHINDRONE [NORETHISTERONE]

Current Illness:

ID: 1811452
Sex: F
Age:
State: PA

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Feverish; Vomiting; Felt sore; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 03Apr2021 at 12:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Concomitant medications included ethinylestradiol/ levonorgestrel (AVIANE) pills taken for birth control from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 04Apr2021 at 00:00, 12 hours after the vaccination, the patient started to feel feverish and then started vomiting. The patient vomited every 10 to 15 minutes for the next 5 hours and could not keep down even water. The patient then felt sore and feverish for the next 15 hours. It was reported that the patient never heard or read of anyone with extensive vomiting as a symptom. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feverish, vomiting and felt sore was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: AVIANE

Current Illness:

ID: 1811453
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Rash; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 10:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received concomitant medications within 2 weeks of vaccinations which was unspecified. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 24Mar2021 at 10:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced rash. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811454
Sex: F
Age:
State: VA

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Fever; Body chills; Body aches; Headache; Nausea; Dose 1 date: 03Mar2021, Dose 2 date: 24Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on 24Apr2021 at 12:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 03Mar2021 at 16:45 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 05:00, the next day, the patient experienced fever, body chills, body aches, headache, and nausea which lasted two days after shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, body chills, body aches, headache and nausea was recovered on 26Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811455
Sex: F
Age:
State: NY

Vax Date: 04/25/2021
Onset Date: 04/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Nausea; Vomiting; Chills; Shaking; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Apr2021 at 16:15 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Concomitant medications included zolpidem (MANUFACTURER UNKNOWN) and hydroxyzine (MANUFACTURER UNKNOWN); for unknown indication from an unknown date and unknown if ongoing. On 26Apr2021, the patient experienced, nausea, vomiting, chills and shaking. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, chills and shaking was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZOLPIDEM; HYDROXYZINE

Current Illness:

ID: 1811456
Sex: M
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Rash; This is a spontaneous report from a contactable consumer (patient). A 57-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0153) via an unspecified route of administration, administered in arm left on 14Apr2021 at 10:00 AM (age at the time of vaccination was 57-years-old) as DOSE 2, SINGLE for COVID-19 immunisation. Facility type vaccine was other, the patient did not take other vaccine in four weeks. Patient had no Covid prior vaccination and was not Covid tested post vaccination. The patient's medical history included Shellfish from an unknown date and unknown if ongoing. The patient took other medications in two weeks. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: ER2613) via an unspecified route of administration, administered in arm left on 24Mar2021 at 10:00 AM (age at time of vaccination was 57-years-old) as DOSE 1, SINGLE for COVID-19 immunisation. On 23Apr2021, the patient experienced rash. No treatment was taken for adverse event rash. The outcome of the event was not recovered. Follow-up attempts are completed. No further information was expected.

Other Meds:

Current Illness:

ID: 1811457
Sex: F
Age:
State: OH

Vax Date: 04/23/2021
Onset Date: 04/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Intense and Debilitating joint/muscle pain from head to toe.; Intense and Debilitating joint/muscle pain from head to toe.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included naproxen (MANUFACTURER UNKNOWN) and ethinylestradiol, norethisterone (NORTREL); both for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation and received cefprozil (CEFZIL) for unknown indication on unknown date and experienced drug allergy. On 26Apr2021 at 03:30, the patient experienced intense and debilitating joint/muscle pain from head to toe. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown, if the patient received any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense and debilitating joint/muscle pain from head to toe was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: NAPROXEN; NORTREL [ETHINYLESTRADIOL;NORETHISTERONE]

Current Illness:

ID: 1811458
Sex: M
Age:
State: GA

Vax Date: 04/21/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Sever stomach pains resulting in 24 hours of diarrhea and vomiting; 24 hours of diarrhea and vomiting.; 24 hours of diarrhea and vomiting.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 21Apr2021 at 07:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 24Apr2021 at 22:00, the patient experienced sever stomach pains resulting in 24 hours of diarrhea and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the events sever stomach pains resulting in 24 hours of diarrhea and vomiting was not recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811459
Sex: F
Age:
State: NY

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Vomiting; Extreme muscle cramps; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 21Apr2021 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had a unspecified medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. On 22Apr2021, the patient experienced vomiting, extreme muscle cramps and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vomiting, extreme muscle cramps and extreme fatigue was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811460
Sex: F
Age:
State: PA

Vax Date: 04/01/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: My lymph nodes in my neck and around my collarbone are swollen and painful; My lymph nodes in my neck and around my collarbone are swollen and painful; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to melons, and berries. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive concomitant medications. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 01Apr2021 at 13:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient previously received cefaclor (CECLOR) and experienced drug allergy. On 23Apr2021 at 06:00, the patients lymph nodes in neck and around collarbone were swollen and painful. The day of report was day 4 since the second shot and she had noticed only a one big swollen lymph node on left collarbone but as the days went by, patient was finding more. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lymph nodes in neck and around collarbone were swollen and painful were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811461
Sex: M
Age:
State: MA

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210422; Test Name: Body temperature; Result Unstructured Data: Test Result:101 Degree

Allergies:

Symptom List: Pain in extremity

Symptoms: 101 degree fever; Chills; Vomiting; Nausea; Headache; Aches; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm right on 21Apr2021 at 13:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included algae oil pills (MANUFACTURER UNKNOWN) and turmeric (MANUFACTURER UNKNOWN) from unknown dates and unknown if ongoing for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8489) via an unspecified route of administration in the arm left on 31Mar2021 at 14:30 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 08:30, the patient experienced 101 degree fever, aches, and chills after 12 hours for 24 hours duration followed by nausea, vomiting and headache for an additional 48 hours. On 22Apr2021 at 08:30, the patient underwent body temperature test and the result was 101 degree with unspecified unites. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 101-degree fever, chills and aches were recovered on 23Apr2021. The clinical outcome of the events vomiting, nausea and headache were recovered on 25Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ALGAE NOS

Current Illness:

ID: 1811462
Sex: F
Age:
State: MN

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Chills; Low-grade fever; Major headache; Nausea; Dehydration; Adverse taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0172) via an unspecified route of administration in the arm right on 24Apr2021 at 10:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram 20mg (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN) and rizatriptan 10 mg (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm right on 03Apr2021 at 10:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021, the patient experienced chills, low-grade fever, major headache, nausea, dehydration and adverse taste in mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, low-grade fever, major headache, nausea, dehydration and adverse taste in mouth was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ESCITALOPRAM; IBUPROFEN; RIZATRIPTAN

Current Illness:

ID: 1811463
Sex: F
Age:
State: NC

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Left arm sore for 3 days; Very tired; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 14:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the vaccination. On 19Apr2021, the patient experienced left arm sore for 3 days and felt very tired for 2 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very tired was resolved on 21Apr2021, after the duration of 2 days and of left arm sore was resolved on 22Apr2021, after the duration of 3 days. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811464
Sex: M
Age:
State: CT

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Rash on both inner forearms; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 15Apr2021 at 18:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included olmesartan (MANUFACTURER UNKNOWN) and curcuma longa rhizome (TURMERIC); both for an unknown indication from an unknown date and unknown if ongoing. On 16Apr2021 at 11:00, the patient experienced rash on both inner forearms. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event rash on both inner forearms was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: OLMESARTAN; TURMERIC [CURCUMA LONGA RHIZOME]

Current Illness:

ID: 1811465
Sex: M
Age:
State: LA

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: a lump in my lymph node on my right collarbone; cough; fatigue; At times I also have trouble focusing; This is a spontaneous report from a contactable consumer (patient). This 58-year-old male patient received dose 2 of BNT162B2 (lot number EP6955) via an unspecified route of administration on 24Mar2021 at 09:30 (at the age of 58-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included gout. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included allopurinol 300 mg from an unknown date for an unknown indication. The patient did not have any known allergies. The patient previously received dose 1 of BNT162B2 (lot number EN6206) on 03Mar2021 at 09:30 as a single dose in the right arm for COVID-19 immunization. On 25Mar2021 at 07:00 the patient developed a lump in his lymph node on his right collarbone. It had reduced in size but was still present. He still had a cough and fatigue. At times he had trouble focusing. The patient visited a doctor or other healthcare professional office/clinic as a result of the events. The patient received treatment with a steroid shot antibiotic shot, and cough medicine. The outcome of lump in his lymph node was recovering. The outcomes of cough, fatigue, and trouble focusing were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.

Other Meds: ALLOPURINOL

Current Illness:

ID: 1811466
Sex: F
Age:
State: PA

Vax Date: 03/31/2021
Onset Date: 04/09/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Broke out in hives; Itchy hands and feet; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included low thyroid, glaucoma and hypertension. The patient had unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC), losartan (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID) and ergocalciferol (VIT D) and unspecified daily multiple; all from unknown date for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the left arm on 10Mar2021 at 11:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 07:00, the patient broke out in hives, itchy hands and feet. The event resulted in emergency room or department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with PREDNISONE, famotidine (PEPCID), cetirizine hydrochloride (ZYRTEC) and diphenhydramine hydrochloride (BENADRYL); all from an unknown date and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events broke out in hives, itchy hands and feet were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; LOSARTAN; SYNTHROID; VIT D [ERGOCALCIFEROL]

Current Illness:

ID: 1811467
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Swelling in the lymph nodes (lymphadenopathy); Very bad headache (headache); This is a spontaneous report from a non-contactable pharmacist. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via intramuscular route of administration on 09Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. It was unknown if the patient had any relevant medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was unknown if the patient received any concomitant mediations. On 10Apr2021, the patient developed swelling in the lymph nodes (lymphadenopathy) and 'very bad headache' (headache) shortly after the 1st dose of the COVID-19 vaccine. Both events lasted for about a week and a half and have resolved. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling in the lymph nodes (lymphadenopathy) and very bad headache (headache) was resolved on an unspecified date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811468
Sex: F
Age:
State: MI

Vax Date: 02/09/2021
Onset Date: 02/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Late/missed menstrual cycle; This is a spontaneous report from a contactable healthcare professional, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via intramuscular route of administration in the left arm on 09Feb2021 at 15:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and factor 5 heterozygous. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included beclometasone dipropionate (QVAR), pantoprazole (MANUFACTURER UNKNOWN), cannabidiol (CBD OIL) and mentha x piperita oil (PEPPERMINT OIL)(IB GARD); all for unknown indication from unknown start date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0142) via intramuscular route of administration in the left arm on 19Jan2021 at 15:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient previously took cefaclor (CECLOR) and experienced drug allergy. On 12Feb2021 the patient experienced late/missed menstrual cycle. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event late/missed menstrual cycle was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: QVAR; PANTOPRAZOLE; CBD OIL; PEPPERMINT OIL [MENTHA X PIPERITA OIL]

Current Illness:

ID: 1811469
Sex: M
Age:
State: NJ

Vax Date: 03/01/2021
Onset Date: 03/08/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Muscle soreness; Rash on fingers; Aches in both shoulder; Exhaustion; Intestinal distress; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 01Mar2021 at 14:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes and pancreatic cancer. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ezetimibe (MANUFACTURER UNKNOWN); taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 29Jan2021 at 14:30 as a single dose for COVID-19 immunisation. On 08Mar2021, the patient experienced muscle soreness, rash on fingers, aches in both shoulder, exhaustion and intestinal distress. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event rash on fingers and included treatment with unspecified steroid and topical. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle soreness, rash on fingers, aches in both shoulder, exhaustion and intestinal distress were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: EZETIMIBE

Current Illness:

ID: 1811470
Sex: F
Age:
State: NY

Vax Date: 02/26/2021
Onset Date: 03/15/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210405; Test Name: PCR; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Acute ringing in ears at an extremely high pitched level; It is constant and wakes me from sleep; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6202) via an unspecified route of administration in the left arm on 26Feb2021 at 16:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included systemic lupus erythematosis (reported as systemic lupus). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included methylprednisolone (MANUFACTURER UNKNOWN) for unknown indication, from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Feb2021 at 14:45 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the vaccination. On 15Mar2021 at 06:00, the patient experienced acute ringing in ears at an extremely high-pitched level. It was constant and woke patient from sleep. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 05Apr2021, the patient underwent Polymerase Chain Reaction (PCR) test for COVID- 19 via nasal swab and the result was negative. The clinical outcome of the events acute ringing in ears at an extremely high-pitched level; it was constant and woke patient from sleep were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METHYLPREDNISOLONE

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am